The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Effect of Altered Plasma Protein Binding on Apparent Volume of Distribution
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
A physiological approach to hepatic drug clearance
Wilkinson, G. R., & Shand, D. G. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975184377 · Cited by 1,873
Plasma and Tissue Protein Binding of Drugs in Pharmacokinetics
Jusko, W. J., & Gretch, M. (1976) · Drug Metabolism Reviews · doi:10.3109/03602537608995839 · Cited by 372
FACTORS AFFECTING DRUG METABOLISM
Gillette, J. R. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46890.x · Cited by 348
Textbook of Medical Physiology
Morris, R. (1962) · Physical Therapy · doi:10.1093/ptj/42.1.61 · Cited by 321
Apparent volumes of distribution and drug binding to plasma proteins and tissues
Gibaldi, M., & McNamara, P. J. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00644611 · Cited by 107
Theoretic aspects of pharmacokinetic drug interactions
Gillette, J. R., & Pang, K. S. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977225part2623 · Cited by 84
Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide
Williams, R. L., Blaschke, T. F., Meffin, P. J., Melmon, K. L., & Rowland, M. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977213301 · Cited by 65
OVERVIEW OF FACTORS AFFECTING DRUG INTERACTIONS
Gillette, J. R. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb27926.x · Cited by 12
Cited by
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
Obach, R. S., Lombardo, F., & Waters, N. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020479 · Cited by 462
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
Schmidt, S., Gonzalez, D., & Derendorf, H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21916 · Cited by 335
Hosea, N. A., Collard, W. T., Cole, S., Maurer, T. S., Fang, R. X., Jones, H., Kakar, S. M., Nakai, Y., Smith, B. J., Webster, R., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009333209 · Cited by 300
Clinical Pharmacokinetics of Teicoplanin
Rowland, M. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018030-00002 · Cited by 263
TOUTAIN, P. L., & BOUSQUET‐MÉLOU, A. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00602.x · Cited by 254
Choi, G.-W., Lee, Y.-B., & Cho, H.-Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040168 · Cited by 79
Species Differences in Distribution and Prediction of Human Vss from Preclinical Data
Berry, L. M., Li, C., & Zhao, Z. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040766 · Cited by 69
Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds
Zhang, T., Heimbach, T., Lin, W., Zhang, J., & He, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24373 · Cited by 56
Metadata
- Authors
- Øie, S., & Tozer, T. N.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1979-09
- Volume
- 68
- Issue
- 9
- Pages
- 1203-1205
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2088755752
- Cited by
- 256
- References
- 9
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.